Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Prometic Life Sciences offers new data from phase II study of PBI-4050 in Alstrom syndrome

March 29, 2018

Lanadelumab submissions in E.U. and Canada accepted for review

March 29, 2018

EMA accepts BioMarin's MAA for pegvaliase to treat adults with PKU

March 29, 2018

Semglee biosimilar insulin glargine approved in E.U. and Australia

March 28, 2018

Sichuan Kelun-Biotech Biopharmaceutical patents thrombopoietin receptor agonists

March 28, 2018

Japan's MHLW grants Sakigake designation to JR-141 for Hunter's syndrome

March 28, 2018

Sujanu combination tablets approved in Japan

March 28, 2018

Japanese approval for Orkedia

March 27, 2018

Sanofi seeks U.S. and E.U. approval for sotagliflozin in type 1 diabetes

March 27, 2018

EMA grants PRIME designation for lumasiran in primary hyperoxaluria type 1

March 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...